Discovery of Benzoxazepines as a New Class of PIM1 Kinase Inhibitors Through Structure Based Virtual Screening, Biochemical Evaluation and Cytotoxicity Studies
- 19 March 2024
- journal article
- research article
- Published by Wiley in ChemistrySelect
- Vol. 9 (12)
Abstract
PIM kinase is a serine/threonine protein kinase implicated in human cancers because it promotes cell proliferation while inhibiting apoptosis and is a crucial target for malignancy. In the present study, we used 700000 commercially available Chembridge small molecules library for structure‐based drug discovery to identify novel potent PIM1 kinase inhibitors. Based on the virtual screening results, ten compounds were chosen and screened enzymatically at 10 μM. Out of ten compounds, only two compounds, 22876894 (61 %) and 58626268 (63 %), inhibited PIM1 kinase. Subsequently, the enzymatic IC 50 value for compounds 22876894 and 58626268 was calculated and found to be 0.8 μM and 3.9 μM. Cell viability was evaluated on human malignant cell lines HCT‐116 (colorectal carcinoma), U‐2OS (osteosarcoma), and non‐cancerous hTERT‐RPE‐1. It was found that compound 22876894 possessed significant inhibitory activity against HCT‐116 (IC 50 =12.1 μM), U‐2OS (IC 50 =23.2 μM), and hTERT‐RPE‐1 (IC 50 =12.7 μM) cell lines. The compound 58626268 possessed significant inhibitory activities against HCT‐116 (IC 50 =28.1 μM), U‐2OS (IC 50 =23.5 μM), and hTERT‐RPE‐1 (IC 50 =21 μM) cell lines. Further, the molecular dynamics simulation of identified compounds (22876894 and 58626268) was performed. Based on kinase profiling, cytotoxicity studies, and molecular dynamics simulation results, we claim 5‐{[7‐(1‐benzothien‐3‐yl)‐9‐hydroxy‐2,3‐dihydro‐1,4‐benzoxazepin‐4(5H)‐yl]carbonyl}pyridin‐2(1H)‐one (22876894) and 4‐(2‐aminoisonicotinoyl)‐7‐(1‐benzothien‐3‐yl)‐2,3,4,5‐tetrahydro‐1,4‐benzoxazepin‐9‐ol (58626268) as a selective and potential PIM1 kinase inhibitors.Keywords
Funding Information
- Indian Council of Medical Research (45/06/2020-BIO/BMS)
This publication has 32 references indexed in Scilit:
- Biological Effects of the Pim Kinase Inhibitor, SGI-1776, in Multiple MyelomaClinical Lymphoma Myeloma and Leukemia, 2013
- Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: Chemistry, biological activities, and molecular modelingBioorganic & Medicinal Chemistry Letters, 2008
- Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinaseBioorganic & Medicinal Chemistry, 2007
- Identification and structure–activity relationships of substituted pyridones as inhibitors of Pim-1 kinaseBioorganic & Medicinal Chemistry Letters, 2007
- Ruthenium Half‐Sandwich Complexes Bound to Protein Kinase Pim‐1Angewandte Chemie International Edition, 2006
- The serine/threonine kinase Pim-1The International Journal of Biochemistry & Cell Biology, 2005
- A hierarchical approach to all‐atom protein loop predictionProteins: Structure, Function, and Bioinformatics, 2004
- Regulation of Pim-1 by Hsp90Biochemical and Biophysical Research Communications, 2001
- The pim‐1 oncogene encodes two related protein‐serine/threonine kinases by alternative initiation at AUG and CUG.The EMBO Journal, 1991
- Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal regionCell, 1984